• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫微环境:家族性腺瘤性息肉病的新见解

Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.

作者信息

Yang Jun, Wen Zhengqi, Li Wenliang, Sun Xianghua, Ma Junrui, She Xueke, Zhang Hongbin, Tu Changling, Wang Guoqiang, Huang Depei, Shen Xudong, Dong Jian, Zhang Hushan

机构信息

Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

Department of Cadre Recuperation, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

出版信息

Front Oncol. 2021 Feb 8;11:570241. doi: 10.3389/fonc.2021.570241. eCollection 2021.

DOI:10.3389/fonc.2021.570241
PMID:33628741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7897671/
Abstract

Currently, the main treatment for familial adenomatous polyposis (FAP) is surgery, however, surgery is far from ideal as there are many complications such as uncontrollable bowel movements, pouch inflammation, anastomotic stricture, and secondary fibroids. Therefore, it is necessary to further expand the understanding of FAP and develop new treatments for FAP. The immune microenvironment including immune cells and cytokines, plays an important role in FAP and the progression of FAP to adenocarcinoma, thus it may be a promising treatment for FAP. In the current review, we summarized the recent progress in the immune microenvironment of FAP.

摘要

目前,家族性腺瘤性息肉病(FAP)的主要治疗方法是手术,然而,手术远非理想选择,因为存在许多并发症,如无法控制的肠道运动、袋状结肠炎、吻合口狭窄和继发性肌瘤。因此,有必要进一步加深对FAP的认识,并开发针对FAP的新治疗方法。包括免疫细胞和细胞因子在内的免疫微环境在FAP以及FAP向腺癌的进展过程中发挥着重要作用,因此它可能是一种有前景的FAP治疗方法。在本综述中,我们总结了FAP免疫微环境的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/9b705b2314af/fonc-11-570241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/5d5b3712b2d4/fonc-11-570241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/8361599d77bb/fonc-11-570241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/9b705b2314af/fonc-11-570241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/5d5b3712b2d4/fonc-11-570241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/8361599d77bb/fonc-11-570241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d19a/7897671/9b705b2314af/fonc-11-570241-g003.jpg

相似文献

1
Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.免疫微环境:家族性腺瘤性息肉病的新见解
Front Oncol. 2021 Feb 8;11:570241. doi: 10.3389/fonc.2021.570241. eCollection 2021.
2
Cancer in an unexpected site post pouch surgery for familial adenomatous polyposis (FAP).家族性腺瘤性息肉病(FAP)行回肠储袋肛管吻合术后在意外部位发生的癌症。
Int J Surg Case Rep. 2018;42:266-268. doi: 10.1016/j.ijscr.2017.12.037. Epub 2017 Dec 28.
3
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.依氟鸟氨酸(CPP-1X)/舒林酸联合疗法与单药疗法治疗家族性腺瘤性息肉病(FAP)患者的疗效和安全性:一项随机、双盲、III期试验的设计与原理
BMC Gastroenterol. 2016 Aug 2;16(1):87. doi: 10.1186/s12876-016-0494-4.
4
The genetic basis of colonic adenomatous polyposis syndromes.结肠腺瘤性息肉病综合征的遗传基础。
Hered Cancer Clin Pract. 2017 Mar 16;15:5. doi: 10.1186/s13053-017-0065-x. eCollection 2017.
5
Is laparoscopic surgery an option to support prophylactic colectomy in adolescent patients with Familial Adenomatous Polyposis (FAP)?腹腔镜手术是否是支持青少年家族性腺瘤性息肉病(FAP)患者预防性结肠切除术的一种选择?
Pediatr Blood Cancer. 2012 Dec 15;59(7):1223-8. doi: 10.1002/pbc.24113. Epub 2012 Feb 29.
6
Adenomatous Polyposis Syndromes: Diagnosis and Management.腺瘤性息肉病综合征:诊断与管理
Clin Colon Rectal Surg. 2016 Dec;29(4):321-329. doi: 10.1055/s-0036-1584089.
7
Pouch-anal cancer after restorative proctocolectomy for familial adenomatous polyposis.家族性腺瘤性息肉病行结直肠切除术后的袋肛癌。
Am J Surg Pathol. 1996 Aug;20(8):995-9. doi: 10.1097/00000478-199608000-00008.
8
Alternative treatments for prophylaxis of colorectal cancer in familial adenomatous polyposis.家族性腺瘤性息肉病中预防结直肠癌的替代治疗方法。
J Anus Rectum Colon. 2018 May 25;1(3):74-77. doi: 10.23922/jarc.2017-007. eCollection 2017.
9
Optimizing the timing of colorectal surgery in patients with familial adenomatous polyposis in clinical practice.在临床实践中优化家族性腺瘤性息肉病患者的结直肠手术时机。
Scand J Gastroenterol. 2019 Jun;54(6):733-739. doi: 10.1080/00365521.2019.1621930. Epub 2019 Aug 11.
10
Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome.一名患有家族性腺瘤性息肉病综合征的患者,胃底腺息肉引发胃腺癌。
Am Surg. 2008 Jan;74(1):79-83.

引用本文的文献

1
IL-17A-producing NKp44(-) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue.产生白细胞介素-17A的NKp44阴性3型天然淋巴细胞在家族性腺瘤性息肉病十二指肠组织中积聚。
Nat Commun. 2025 Apr 25;16(1):3873. doi: 10.1038/s41467-025-58907-y.
2
Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche.间歇性低剂量厄洛替尼联合舒林酸通过上调主要组织相容性复合体及重塑免疫细胞微环境发挥抗肿瘤疗效。
Int J Cancer. 2025 Jul 15;157(2):355-370. doi: 10.1002/ijc.35409. Epub 2025 Mar 12.
3
Familial Polyposis and Colon Cancer.

本文引用的文献

1
Ileal-anal pouches: A review of its history, indications, and complications.回肠肛管袋:回顾其历史、适应证和并发症。
World J Gastroenterol. 2019 Aug 21;25(31):4320-4342. doi: 10.3748/wjg.v25.i31.4320.
2
Targeting Treg cells in cancer immunotherapy.在癌症免疫治疗中靶向调节性 T 细胞。
Eur J Immunol. 2019 Aug;49(8):1140-1146. doi: 10.1002/eji.201847659. Epub 2019 Jul 5.
3
Reactive oxygen species: The signal regulator of B cell.活性氧:B 细胞的信号调节剂。
家族性息肉病与结肠癌
South Asian J Cancer. 2025 Jan 28;13(4):305-308. doi: 10.1055/s-0045-1802333. eCollection 2024 Oct.
4
Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis.家族性腺瘤性息肉病的致癌分子途径。
Int J Mol Sci. 2023 Mar 16;24(6):5687. doi: 10.3390/ijms24065687.
5
NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.NF-κB 激活物 1 在巨噬细胞中的下调激活 STAT3,促进结直肠癌细胞腺瘤-腺癌转化和免疫抑制。
BMC Med. 2023 Mar 29;21(1):115. doi: 10.1186/s12916-023-02791-0.
6
The Effect of Salmonella AvrA Infection on Colon Cancer: An in-silico Study.沙门氏菌 AvrA 感染对结肠癌的影响:一项计算机模拟研究。
Asian Pac J Cancer Prev. 2023 Jan 1;24(1):163-170. doi: 10.31557/APJCP.2023.24.1.163.
7
Familial Adenomatous Polyposis: Case Report and Literature Review.家族性腺瘤性息肉病:病例报告与文献综述。
Cureus. 2022 Nov 17;14(11):e31609. doi: 10.7759/cureus.31609. eCollection 2022 Nov.
8
In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps.计算机模拟鉴定正常结肠组织向腺瘤性息肉转变过程中的关键因子的新型生物标志物。
PLoS One. 2022 Apr 29;17(4):e0267973. doi: 10.1371/journal.pone.0267973. eCollection 2022.
9
The Adaptive Immune Landscape of the Colorectal Adenoma-Carcinoma Sequence.结直肠腺瘤-癌序列中的适应性免疫景观。
Int J Mol Sci. 2021 Sep 10;22(18):9791. doi: 10.3390/ijms22189791.
Free Radic Biol Med. 2019 Oct;142:16-22. doi: 10.1016/j.freeradbiomed.2019.06.004. Epub 2019 Jun 8.
4
Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.结直肠癌:癌症免疫学和免疫治疗的典范模型。
Mol Aspects Med. 2019 Oct;69:123-129. doi: 10.1016/j.mam.2019.05.003. Epub 2019 Jun 4.
5
Mechanisms of natural killer cell-mediated cellular cytotoxicity.自然杀伤细胞介导的细胞毒性的机制。
J Leukoc Biol. 2019 Jun;105(6):1319-1329. doi: 10.1002/JLB.MR0718-269R. Epub 2019 May 20.
6
IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer.IFN/STAT 信号通路控制结直肠癌的肿瘤发生和药物反应。
Cancer Sci. 2019 Apr;110(4):1293-1305. doi: 10.1111/cas.13964. Epub 2019 Mar 22.
7
Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC.免疫排斥 - Wnt/CTNNB1 类预测 HCC 对免疫治疗的耐药性。
Clin Cancer Res. 2019 Apr 1;25(7):2021-2023. doi: 10.1158/1078-0432.CCR-18-3778. Epub 2019 Jan 7.
8
Management of Familial Adenomatous Polyposis in Children and Adolescents: Position Paper From the ESPGHAN Polyposis Working Group.儿童和青少年家族性腺瘤性息肉病的管理:ESPEN 息肉病工作组立场文件。
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):428-441. doi: 10.1097/MPG.0000000000002247.
9
Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1.糖代谢减速通过靶向 SATB1 阻碍 IgG 产生的 B 细胞介导的肿瘤消除。
Immunology. 2019 Jan;156(1):56-68. doi: 10.1111/imm.12998. Epub 2018 Oct 10.
10
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.CD39 和 CD103 的共表达鉴定了人类实体瘤中肿瘤反应性 CD8 T 细胞。
Nat Commun. 2018 Jul 13;9(1):2724. doi: 10.1038/s41467-018-05072-0.